This is an open label study of subjects who have failed Protocol PGN-1300. Adult subjects (greater than 18 years old) who present with a mildly infected diabetic foot ulcer (IDSA criteria) having full thickness (i.e., through the dermis but not involving joint capsule, tendon, and bone) and have failed PGN-1300. Subjects must also provide informed consent and meet all other entry criteria to be enrolled and receive PluroGel PN.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
15
Ledesma Foot and Ankle
Phoenix, Arizona, United States
Foot & Ankle Clinic
Los Angeles, California, United States
Samuel Merritt University
Clinical Response
Clinical Response is defined by the investigator's evaluation of the signs and symptoms of clinical infection.
Time frame: 14 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Oakland, California, United States
ASAP Urgent-Care
Hamden, Connecticut, United States
Advance Medical Research Center
Miami, Florida, United States
Miami Center for Clinical Research, LLC
Miami, Florida, United States
Unlimited Medical Research, LLC
Miami, Florida, United States
Phoenix Medical Research, LLC
Miami, Florida, United States
Med Research of Florida, LCC
Miami, Florida, United States
Sweet Hope Research Specialty, Inc.
Miami Lakes, Florida, United States
...and 5 more locations